76 related articles for article (PubMed ID: 38706713)
1. Fibroblast Activation Protein Inhibitor Theranostics: Early Clinical Translation.
Mori Y; Kratochwil C; Haberkorn U; Giesel FL
PET Clin; 2023 Jul; 18(3):419-428. PubMed ID: 37030981
[TBL] [Abstract][Full Text] [Related]
2. Development and Characterization of Novel FAP-Targeted Theranostic Pairs: A Bench-to-Bedside Study.
Huang W; Pang Y; Liu Q; Liang C; An S; Wu Q; Zhang Y; Huang G; Chen H; Liu J; Wei W
Research (Wash D C); 2023; 6():0282. PubMed ID: 38706713
[TBL] [Abstract][Full Text] [Related]
3. Development of Fibroblast Activation Protein Inhibitor-Based Dimeric Radiotracers with Improved Tumor Retention and Antitumor Efficacy.
Zhao L; Chen J; Pang Y; Fang J; Fu K; Meng L; Zhang X; Guo Z; Wu H; Sun L; Su G; Lin Q; Chen H
Mol Pharm; 2022 Oct; 19(10):3640-3651. PubMed ID: 35917335
[TBL] [Abstract][Full Text] [Related]
4. Preclinical Development of PNT6555, a Boronic Acid-Based, Fibroblast Activation Protein-α (FAP)-Targeted Radiotheranostic for Imaging and Treatment of FAP-Positive Tumors.
Poplawski SE; Hallett RM; Dornan MH; Novakowski KE; Pan S; Belanger AP; Nguyen QD; Wu W; Felten AE; Liu Y; Ahn SH; Hergott VS; Jones B; Lai JH; McCann JAB; Bachovchin WW
J Nucl Med; 2024 Jan; 65(1):100-108. PubMed ID: 38050111
[TBL] [Abstract][Full Text] [Related]
5. A radiohybrid theranostics ligand labeled with fluorine-18 and lutetium-177 for fibroblast activation protein-targeted imaging and radionuclide therapy.
Yang T; Peng L; Qiu J; He X; Zhang D; Wu R; Liu J; Zhang X; Zha Z
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2331-2341. PubMed ID: 36864362
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast Activation Protein Targeting Probe with Gly-Pro Sequence for PET of Glioblastoma.
Lai C; Cao R; Li R; He C; Wang X; Shi H; Qu C; Qian K; Song S; Chen WH; Cheng Z
Mol Pharm; 2023 Aug; 20(8):4120-4128. PubMed ID: 37487027
[TBL] [Abstract][Full Text] [Related]
7. Development of FAPI Tetramers to Improve Tumor Uptake and Efficacy of FAPI Radioligand Therapy.
Pang Y; Zhao L; Fang J; Chen J; Meng L; Sun L; Wu H; Guo Z; Lin Q; Chen H
J Nucl Med; 2023 Sep; 64(9):1449-1455. PubMed ID: 37321827
[TBL] [Abstract][Full Text] [Related]
8. The First-in-Human Whole-Body Dynamic Pharmacokinetics Study of Aptamer.
Ding D; Zhao H; Wei D; Yang Q; Yang C; Wang R; Chen Y; Li L; An S; Xia Q; Huang G; Liu J; Xiao Z; Tan W
Research (Wash D C); 2023; 6():0126. PubMed ID: 37223462
[TBL] [Abstract][Full Text] [Related]
9. Furan Donor for NIR-II Molecular Fluorophores with Enhanced Bioimaging Performance.
Liu C; Li M; Ma H; Hu Z; Wang X; Ma R; Jiang Y; Sun H; Zhu S; Liang Y
Research (Wash D C); 2023; 6():0039. PubMed ID: 37040521
[TBL] [Abstract][Full Text] [Related]
10. Emerging Nano-/Biotechnology Drives Oncolytic Virus-Activated and Combined Cancer Immunotherapy.
Fang C; Xiao G; Wang T; Song L; Peng B; Xu B; Zhang K
Research (Wash D C); 2023; 6():0108. PubMed ID: 37040283
[TBL] [Abstract][Full Text] [Related]
11. Development and Characterization of Nanobody-Derived CD47 Theranostic Pairs in Solid Tumors.
Zhang Y; Zhang D; An S; Liu Q; Liang C; Li J; Liu P; Wu C; Huang G; Wei W; Liu J
Research (Wash D C); 2023; 6():0077. PubMed ID: 36939440
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast activation protein-targeted radionuclide therapy: background, opportunities, and challenges of first (pre)clinical studies.
Privé BM; Boussihmad MA; Timmermans B; van Gemert WA; Peters SMB; Derks YHW; van Lith SAM; Mehra N; Nagarajah J; Heskamp S; Westdorp H
Eur J Nucl Med Mol Imaging; 2023 Jun; 50(7):1906-1918. PubMed ID: 36813980
[TBL] [Abstract][Full Text] [Related]
13. Three-Time-Point PET Analysis of
Naeimi M; Choyke PL; Dendl K; Mori Y; Staudinger F; Watabe T; Koerber SA; Röhrich M; Debus J; Kratochwil C; Haberkorn U; Giesel FL
J Nucl Med; 2023 Apr; 64(4):618-622. PubMed ID: 36357183
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]